The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC

References

• Hall W, Bellb J, Carless J. Crime and drug use among applicants for methadone maintenance. Drug Alcohol Depend. 1989;31(1993):123–129. doi:10.1016/0376-8716(93)90064-W
   Google Scholar
• Teesson M, Marel C, Darke S, et al. Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian treatment outcome study. Addiction. 2015;110(6):986–993. doi:10.1111/add.12860
   PubMed Web of Science ®Google Scholar
• Pierce M, Hayhurst K, Bird SM, et al. Insights into the link between drug use and criminality: lifetime offending of criminally-active opiate users. Drug Alcohol Depend. 2017;179:309–316. doi:10.1016/j.drugalcdep.2017.07.024
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Whiteford H, Hall WD. The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease? Drug Alcohol Rev. 2014;33(1):4–12. doi:10.1111/dar.12088
   PubMed Web of Science ®Google Scholar
• Jiang R, Lee I, Lee TA, Pickard AS. The societal cost of heroin use disorder in the United States. PLoS One. 2017;12(5). doi:10.1371/journal.pone.0177323
   Web of Science ®Google Scholar
• Rolles S, Murkin G, Powell M, Kushlick D, Slater J. The alternative world drug report: counting the costs of the war on drugs; 2012.
   Google Scholar
• Lind B, Chen S, Weatherburn D, Mattick R. The effectiveness of methadone maintenance treatment in controlling crime: an Australian aggregate-level analysis. Brit J Criminol. 2005;45(2):201–211. doi:10.1093/bjc/azh085
   Web of Science ®Google Scholar
• Sun HM, Li XY, Chow EPF, et al. Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open. 2015;5(1):e005997. doi:10.1136/bmjopen-2014-005997
   PubMed Web of Science ®Google Scholar
• Bukten A, Skurtveit S, Gossop M, et al. Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study. Addiction. 2012;107(2):393–399. doi:10.1111/j.1360-0443.2011.03637.x
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2014(2). doi:10.1002/14651858.CD002207.pub4
   PubMed Web of Science ®Google Scholar
• Piske M, Zhou H, Min JE, et al. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada. Addiction. 2020;115(8):1482–1493. doi:10.1111/add.14947
   PubMed Web of Science ®Google Scholar
• Pearce LA, Min JE, Piske M, et al. Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. BMJ. 2020:368. doi:10.1136/bmj.m772
   Google Scholar
• Russolillo A, Moniruzzaman A, McCandless LC, Patterson M, Somers JM. Associations between methadone maintenance treatment and crime: a 17-year longitudinal cohort study of Canadian provincial offenders. Addiction. 2018;113(4):656–667. doi:10.1111/add.14059
   PubMed Web of Science ®Google Scholar
• Vogel M, Meyer M, Westenberg JN, et al. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study. Harm Reduct J. 2023;20(1). doi:10.1186/s12954-023-00731-y
   PubMed Web of Science ®Google Scholar
• National Safer Supply Community of Practice. Emerging evidence brief on prescribed safer supply and client experiences; 2023.
   Google Scholar
• Oviedo-Joekes E, Brissette S, Marsh DC, et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361(8):777–786. doi:10.1056/nejmoa0810635
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes E, Guh D, Brissette S, et al. Hydromorphone compared with diacetylmorphine for long-term opioid dependence. JAMA Psychiatry. 2016;73(5):447. doi:10.1001/jamapsychiatry.2016.0109
   PubMed Web of Science ®Google Scholar
• Strang J, Groshkova T, Uchtenhagen A, et al. Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction. Br J Psychiatry. 2015;207(1):5–14. doi:10.1192/bjp.bp.114.149195
   PubMed Web of Science ®Google Scholar
• Haasen C, Verthein U, Degkwitz P, Berger J, Krausz M, Naber D. Heroin-assisted treatment for opioid dependence: randomised controlled trial. Br J Psychiatry. 2007;191(JULY):55–62. doi:10.1192/bjp.bp.106.026112
   PubMedGoogle Scholar
• Demaret I, Quertemont E, Litran G, et al. Efficacy of heroin-assisted treatment in Belgium: a randomised controlled trial. Eur Addict Res. 2015;21(4):179–187. doi:10.1159/000369337
   PubMed Web of Science ®Google Scholar
• Nosyk B, Guh DP, Bansback NJ, et al. Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ. 2012;184(6):E317–E328. doi:10.1503/cmaj.110669
   PubMed Web of Science ®Google Scholar
• Byford S, Barrett B, Metrebian N, et al. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. Br J Psychiatry. 2013;203(5):341–349. doi:10.1192/bjp.bp.112.111583
   PubMed Web of Science ®Google Scholar
• Bansback N, Guh D, Oviedo-Joekes E, et al. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial. Addiction. 2018;113(7):1264–1273. doi:10.1111/add.14171
   PubMed Web of Science ®Google Scholar
• Ribeaud D. Long-term impacts of the Swiss Heroin prescription trials on crime of treated heroin users. J Drug Issues. 2004;34(1):163–194. doi:10.1177/002204260403400108
   Web of Science ®Google Scholar
• Smart R, Reuter P. Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials. Addiction. 2022;117(3):518–531. doi:10.1111/add.15601
   PubMed Web of Science ®Google Scholar
• Oviedo-Joekes E, Marchand K, Lock K, Macdonald S, Guh D, Schechter MT The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency; 2015. Available from: http://www.substanceabusepolicy.com/content/10/1/3. November 08, 2023.
   Google Scholar
• Oviedo-Joekes E, Marchand K, Macdonald DS, Krausz M History of treatment access and drug use among participants in a trial testing injectable opioids under supervision for long-term heroin injectors; 2015. Available from: https://www.researchgate.net/publication/278406606. November 08, 2023.
   Google Scholar
• Volkow ND, Poznyak V, Saxena S, Gerra G. Drug use disorders: impact of a public health rather than a criminal justice approach. World J Psychiatry. 2017;16(2):213–214. doi:10.1002/wps.20428
   Google Scholar
• Havnes I, Bukten A, Gossop M, Waal H, Stangeland P, Clausen T. Reductions in convictions for violent crime during opioid maintenance treatment: a longitudinal national cohort study. Drug Alcohol Depend. 2012;124(3):307–310. doi:10.1016/j.drugalcdep.2012.02.005
   PubMed Web of Science ®Google Scholar
• Zhong S, Yu R, Fazel S. Drug use disorders and violence: associations with individual drug categories. Epidemiol Rev. 2020;42(1):103–116. doi:10.1093/epirev/mxaa006
   PubMed Web of Science ®Google Scholar
• Sanders B, Lankenau SE, Bloom JJ, Hathaz DS. A typology of drug-related offending among youth homeless injection drug users. J Drug Issues. 2009;39(4):777–802. doi:10.1177/002204260903900401
   PubMed Web of Science ®Google Scholar
• Håkansson A, Jesionowska V. Associations between substance use and type of crime in prisoners with substance use problems – a focus on violence and fatal violence. Subst Abuse Rehabil. 2018;9:1–9. doi:10.2147/sar.s143251
   PubMed Web of Science ®Google Scholar
• Sutherland R, Sindicich N, Barrett E, et al. Motivations, substance use and other correlates amongst property and violent offenders who regularly inject drugs. Addict Behav. 2015;45:207–213. doi:10.1016/j.addbeh.2015.01.034
   PubMed Web of Science ®Google Scholar
• Ellefsen R, Wüsthoff LEC, Arnevik EA. Patients’ satisfaction with heroin-assisted treatment: a qualitative study. Harm Reduct J. 2023;20(1):73. doi:10.1186/s12954-023-00808-8
   PubMed Web of Science ®Google Scholar
• McElrath K, Chitwood DD, Comerford M. Crime victimization among injection drug users. J Drug Issues. 1997;27(4):771–783. doi:10.1177/002204269702700406
   Web of Science ®Google Scholar
• Seid AK, Hesse M, Houborg E, Thylstrup B. Substance use and violent victimization: evidence from a cohort of >82,000 patients treated for alcohol and drug use disorder in Denmark. J Interpers Violence. 2022;37(13–14):NP12427–NP12452. doi:10.1177/0886260521997456
   PubMed Web of Science ®Google Scholar
• French MT, Mccollister KE, Alexandre PK, Chitwood DD, Mccoy CB. Revolving roles in drug-related crime: the cost of chronic drug users as victims and perpetrators. J Quant Criminol. 2004;20(3):217–241. doi:10.1023/B:JOQC.0000037732.00489.ad
   Web of Science ®Google Scholar
• Butler A, Zakimi N, Greer A. Total systems failure: police officers’ perspectives on the impacts of the justice, health, and social service systems on people who use drugs. Harm Reduct J. 2022;19(1). doi:10.1186/s12954-022-00629-1
   Web of Science ®Google Scholar
• Nicosia N, MacDonald JM, Arkes J. Disparities in criminal court referrals to drug treatment and prison for minority men. Am J Public Health. 2013;103(6):e77–e84. doi:10.2105/AJPH.2013.301222
   PubMed Web of Science ®Google Scholar
• Meyer M, Westenberg JN, Strasser J, et al. Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment. Harm Reduct J. 2022;19(1). doi:10.1186/s12954-022-00644-2
   PubMed Web of Science ®Google Scholar
• British Columbia Government. Decriminalizing people who use drugs in B.C; 2023. Available from: https://www2.gov.bc.ca/gov/content/overdose/decriminalization#:~:text=Under%20this%20exemption%2C%20adults%20(18,Crack%20and%20powder%20cocaine. Accessed October 21, 2023.
   Google Scholar
• Oviedo-Joekes E, Dobischok S, Carvajal J, et al. Clients’ experiences on North America’s first take-home injectable opioid agonist treatment (iOAT) program: a qualitative study. BMC Health Serv Res. 2023;23(1):553. doi:10.1186/s12913-023-09558-6
   PubMedGoogle Scholar